Prospective Cohort Study of Patients With Infective Endocarditis at Pitié-Salpêtrière Hospital
Doctors at Pitié-Salpêtrière Hospital in Paris are running a study on a serious heart infection called infective endocarditis. This condition is quite rare, so there's not a lot of detailed information about it. The study aims to collect important data from patients with this infection, as it can cause severe problems like strokes. By understanding more about how the infection progresses and affects people, the hope is to develop better ways to manage it and improve patients' chances of recovery. Participants will have their health information collected regularly for up to 10 years after their diagnosis, helping researchers learn valuable long-term insights.
At a glance
What is this study about?
Infective endocarditis is a serious infection that affects the lining of your heart or its valves. Because it's not very common, doctors haven't had a chance to gather a lot of detailed information directly from patients over time. This makes it harder for them to develop the best possible treatments and advice. This study, taking place at the Pitié-Salpêtrière Hospital in Paris, aims to change that by carefully looking at many patients with this condition.
The main goal is to understand infective endocarditis better. This infection can be very dangerous and sometimes leads to other serious problems, like strokes. By collecting detailed information about how the infection affects people, how it's treated, and how patients recover, researchers hope to find new ways to improve care and reduce the risk of complications. This kind of research is really important because it helps doctors make more informed decisions based on real patient experiences.
Over many years, the information gathered from this study could lead to significant improvements in how infective endocarditis is diagnosed, treated, and managed. Ultimately, this means better health and fewer serious problems for people who get this infection in the future. The study is a long-term effort to build a strong foundation of knowledge that can help both current and future patients.
Key takeaways
- Study collects information on heart infection (infective endocarditis).
- Aims to improve future treatment and care.
- Takes place at Pitié-Salpêtrière Hospital in Paris.
- No new treatments or medicines; standard care provided.
- Information collected for up to 10 years.
- You can withdraw from the study at any time without affecting your care.
Who may be eligible?
To be part of this study, you need to meet certain requirements. The most important one is that you must have been diagnosed with infective endocarditis. This diagnosis needs to be confirmed by doctors following specific European guidelines.
This study is for adults, meaning you need to be 18 years old or older. Both men and women can take part. If you meet these main criteria, you might be able to join.
The only reason you wouldn't be able to join is if you or your legal guardian decided you didn't want to participate in the study. Your choice not to join will not affect your medical care in any way.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Have I been diagnosed with infective endocarditis?
- Is my diagnosis confirmed by my doctors using European guidelines?
- Am I 18 years old or older?
- Am I happy for my health information to be used for research?
What does participation involve?
If you decide to take part in this study, the doctors at Pitié-Salpêtrière Hospital will collect information about your health. This will involve gathering details about you when you are first diagnosed with infective endocarditis, such as your age, other health conditions, and the results of tests like blood work and scans. They will continue to collect this kind of information as you receive treatment and during your follow-up appointments.
You won't be given any new medications or treatments specially for this study. All your care will be based on what your doctors normally recommend for infective endocarditis. What's different is that your health information will be carefully recorded and stored for research purposes. The study will follow you for a very long time, up to 10 years after you join. This means that doctors will continue to check on your health and collect updates during your regular hospital visits over that period, helping them understand the long-term effects of the illness.
Potential risks and benefits
Locations (1)
- APHP Pitié-Salpêtrière Hospital, Department of CardiologyVerified postcodeParis, France· Recruiting
Common questions
What is infective endocarditis?
It's a serious infection of the inner lining of your heart or its valves.
Where is this study taking place?
It's happening at the Pitié-Salpêtrière Hospital in Paris, France.
Will I have to take new medicines?
No, you will receive the standard medical care for your condition; no new treatments are given as part of this study.
How long will I be followed in the study?
Doctors will follow your health for up to 10 years after you join the study.
Can I decide not to be in the study?
Yes, you can choose not to participate at any time, and it won't affect your medical care.
How to find out more
Nadjib Hammoudi, MD, PhD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.